Growth factor release from tissue engineering scaffolds.
about
Magnetic poly(ε-caprolactone)/iron-doped hydroxyapatite nanocomposite substrates for advanced bone tissue engineering.Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: engineering cell-invasion characteristicsDelivery systems for bone growth factors - the new players in skeletal regeneration.Biodegradable scaffolds--delivery systems for cell therapies.Molecular aspects of tissue engineering in the dental field.Tissue engineered nerve constructs: where do we stand?Gene therapy used for tissue engineering applications.A Heparin-Mimicking Block Copolymer Both Stabilizes and Increases the Activity of Fibroblast Growth Factor 2 (FGF2).Fabrication and characterization of biomimetic multichanneled crosslinked-urethane-doped polyester tissue engineered nerve guides.Tissue scaffolds for skin wound healing and dermal reconstruction.Dermal substitute-assisted healing: enhancing stem cell therapy with novel biomaterial design.Functionalized synthetic biodegradable polymer scaffolds for tissue engineering.Emerging roles for biomaterials in the treatment of liver disease.Strategies to improve regeneration of the soft palate muscles after cleft palate repair.Design and synthesis of binding growth factors.Bone substitutes in orthopaedic surgery: from basic science to clinical practice.Use of Pig as a Model for Mesenchymal Stem Cell Therapies for Bone Regeneration.Covalent binding of BMP-2 on surfaces using a self-assembled monolayer approach.Approaches for building bioactive elements into synthetic scaffolds for bone tissue engineering.The fabrication of iron oxide nanoparticle-nanofiber composites by electrospinning and their applications in tissue engineering.Bioactive scaffolds for engineering vascularized cardiac tissues.Fabrication and characterization of poly(DL-lactic-co-glycolic acid)/zirconia-hybridized amorphous calcium phosphate composites.Incorporation of proteins within alginate fibre-based scaffolds using a post-fabrication entrapment method.Peptide-directed self-assembly of functionalized polymeric nanoparticles. Part II: effects of nanoparticle composition on assembly behavior and multiple drug loading ability.In vitro release of dexamethasone or bFGF from chitosan/hydroxyapatite scaffolds.Platelet-rich plasma-loaded chitosan scaffolds: preparation and growth factor release kinetics.Semi-interpenetrating network of poly(ethylene glycol) and poly(D,L-lactide) for the controlled delivery of protein drugs.A novel personalized 3D injectable protein scaffold for regenerative medicine.Covalent Binding of Bone Morphogenetic Protein-2 and Transforming Growth Factor-β3 to 3D Plotted Scaffolds for Osteochondral Tissue Regeneration.Isolation and Culture of Embryonic Stem Cells, Mesenchymal Stem Cells, and Dendritic Cells from Humans and Mice.Poly(3,4-ethylenedioxythiophene) nanoparticle and poly(ɛ-caprolactone) electrospun scaffold characterization for skeletal muscle regeneration.Scaffolds for Growth Factor Delivery as Applied to Bone Tissue Engineering
P2860
Q34543166-8C69DD18-B125-4129-B979-0D28F302666EQ34983148-4EFA6406-B5F2-4450-ADFD-9C1049CDF856Q35751776-FDB91157-5268-485F-AE94-8B093FCF25F7Q36446937-83BE1E7B-3E98-40F0-B706-1E8E1F3AD721Q36474276-7CF73A94-554C-4545-8646-B7ABAEC5F935Q36517051-96C7EF17-82AF-476A-9A03-FB17E2C1BF04Q36748645-C3401706-F6D1-498E-9E74-8D232435ECE5Q37330610-5A3891E6-70E6-4202-A1B4-98A2897E2936Q37662872-CA416750-6480-4CA2-B7DD-61BF039A5936Q37770471-F1BA89FD-CBC8-4426-82A4-E14F5F25F636Q37848691-E05F9229-2BEF-4B3A-BC89-8D423152A8E5Q37991268-1E8D3D62-8C72-42D8-B54C-4197880F8A10Q37992205-D45F4080-B552-4EF9-A968-3D04F2B468ECQ38018659-1F6CC456-0785-48F6-A675-6A94F70ED05DQ38023393-32DBA4F5-2638-424F-A937-0ECD369867FAQ38215317-73B345BA-BA7D-4593-92ED-3B38685B8822Q38924988-B40DD7FE-A4A1-43E1-80CE-63DD2293ECA2Q39097701-AD1F6C73-5377-452A-B9FA-EB75F4A8FFCCQ39108532-3001D105-B22A-4211-B0E5-7C5433B75661Q39387606-E477EC33-E6C3-4385-9785-24B7FA700B3AQ39653342-A84E7C6B-A517-43A1-9B2A-25E931BF9480Q42058679-24FAB828-C333-47B5-B50F-C5E8A89CA4E4Q42799721-EC2C834D-6E42-4B64-B396-9AA77AFF823EQ42832604-0F9B23C4-DE6F-4424-ADE0-544B117D538FQ43269043-9C4CCB76-C428-4EF2-AE35-E8E21D729AD8Q43875780-374D5B34-0641-4CCD-AA77-400D4743B2A5Q46407467-AF1C5CAA-BB0E-49CE-A7D2-E6DDEA28149EQ47291343-81833C53-881E-48B9-B715-1E15298A3D32Q47725597-84A34FB8-419E-4787-A58C-AA384DDCFE61Q51512284-9A6BF12B-0890-44A5-BDFF-CB40C3485813Q53552367-6028E986-CD6B-476E-93AA-56E5E929C38BQ58689174-E834E59F-949F-438B-9541-1D3B88D4386D
P2860
Growth factor release from tissue engineering scaffolds.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Growth factor release from tissue engineering scaffolds.
@ast
Growth factor release from tissue engineering scaffolds.
@en
Growth factor release from tissue engineering scaffolds.
@nl
type
label
Growth factor release from tissue engineering scaffolds.
@ast
Growth factor release from tissue engineering scaffolds.
@en
Growth factor release from tissue engineering scaffolds.
@nl
prefLabel
Growth factor release from tissue engineering scaffolds.
@ast
Growth factor release from tissue engineering scaffolds.
@en
Growth factor release from tissue engineering scaffolds.
@nl
P2860
P356
P1476
Growth factor release from tissue engineering scaffolds
@en
P2093
M J Whitaker
S M Howdle
P2860
P304
P356
10.1211/0022357011777963
P577
2001-11-01T00:00:00Z